121 related articles for article (PubMed ID: 3004430)
1. Evidence for an antagonist specific receptor that does not bind mineralocorticoid agonists.
Lazar G; Agarwal MK
Biochem Biophys Res Commun; 1986 Jan; 134(1):261-5. PubMed ID: 3004430
[TBL] [Abstract][Full Text] [Related]
2. Activation of mineralocorticoid agonist and antagonist specific receptors from rat kidney.
Agarwal MK; Kalimi M
Biochem Biophys Res Commun; 1987 Feb; 143(1):398-402. PubMed ID: 3030321
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical differences in the receptor binding of two new antimineralocorticoids.
Agarwal MK; Kalimi M
Biochim Biophys Acta; 1988 Jan; 964(1):105-12. PubMed ID: 2825817
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship of new steroidal aldosterone antagonists. Comparison of the affinity for mineralocorticoid receptors in vitro and the antialdosterone activity in vivo.
Wambach G; Casals-Stenzel J
Biochem Pharmacol; 1983 May; 32(9):1479-85. PubMed ID: 6222738
[TBL] [Abstract][Full Text] [Related]
5. Characterization of spironolactone binding sites distinct from aldosterone receptors in rat kidney homogenates.
Luzzani F; Glässer A
Biochem Pharmacol; 1984 Jul; 33(14):2277-81. PubMed ID: 6235813
[TBL] [Abstract][Full Text] [Related]
6. RU-26988--a new tool for the study of the mineralocorticoid receptor.
Gomez-Sanchez CE; Gomez-Sanchez EP
Endocrinology; 1983 Sep; 113(3):1004-9. PubMed ID: 6307658
[TBL] [Abstract][Full Text] [Related]
7. Binding of natural spirolactone derivatives to mineralo- and glucocorticoid receptors of the rat kidney.
Palem-Vliers M; Genard P; Hacha R; Christiaens L; Lomba-Pignon MR
Arch Int Physiol Biochim; 1987 Nov; 95(4):373-4. PubMed ID: 2453182
[No Abstract] [Full Text] [Related]
8. Different mechanisms for the receptor mediated antimineralocorticoid action of two new spirolactone derivatives.
Agarwal MK; Kalimi M
Biochem Biophys Res Commun; 1988 Jan; 150(1):449-55. PubMed ID: 2827677
[TBL] [Abstract][Full Text] [Related]
9. Properties and distribution of binding sites for the mineralocorticoid receptor antagonist [3H]ZK 91587 in brain.
Grillo C; Vallee S; McEwen BS; De Nicola AF
J Steroid Biochem; 1990 Jan; 35(1):11-5. PubMed ID: 2155344
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid (type I) receptors in the olfactory mucosa of the mammal: studies with [3H]aldosterone and the anti-mineralocorticoid spironolactone.
Kern RC; Foster JD; Pitovski DZ
Chem Senses; 1997 Apr; 22(2):141-8. PubMed ID: 9146904
[TBL] [Abstract][Full Text] [Related]
11. Binding and antimineralocorticoid activities of spirolactones in toad bladder.
Rossier BC; Claire M; Rafestin-Oblin ME; Geering K; Gäggeler HP; Corvol P
Am J Physiol; 1983 Jan; 244(1):C24-31. PubMed ID: 6217754
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the mineralocorticoid receptor in rat heart with the aid of two new spirolactone derivatives.
Agarwal MK; Kalimi M
Biochem Med Metab Biol; 1989 Feb; 41(1):36-45. PubMed ID: 2540779
[TBL] [Abstract][Full Text] [Related]
13. Binding of spironolactone metabolites in vivo to renal mineralocorticoid receptors in guinea pigs.
Los LE; Colby HD
Pharmacology; 1994 Feb; 48(2):86-92. PubMed ID: 8134406
[TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid hormone action in plant cells.
Mirshahi M; Mirshahi A; Nato A; Agarwal MK
Biochem Biophys Res Commun; 1992 Jul; 186(2):1102-7. PubMed ID: 1323283
[TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid and renal receptor binding activity of 21-deoxyaldosterone.
Koshida H; Miyamori I; Soma R; Matsubara T; Ikeda M; Takeda R; Nakamura S; Kiuchi F; Tsuda Y
Endocrinology; 1990 Mar; 126(3):1410-5. PubMed ID: 2155101
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid receptors in the epithelial cells of human colon and ileum.
Rafestin-Oblin ME; Lombes M; Michiel JB; Michaud A; Claire M
J Steroid Biochem; 1984 Jan; 20(1):311-5. PubMed ID: 6323865
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid specificity of renal type I receptors: in vivo binding studies.
Sheppard K; Funder JW
Am J Physiol; 1987 Feb; 252(2 Pt 1):E224-9. PubMed ID: 3030124
[TBL] [Abstract][Full Text] [Related]
18. Renal receptor-binding activity of reduced metabolites of aldosterone: evidence for a mineralocorticoid effect outside of the classic aldosterone receptor system.
Gomez-Sanchez CE; Smith JS; Ferris MW; Gomez-Sanchez EP
Endocrinology; 1984 Aug; 115(2):712-5. PubMed ID: 6086276
[TBL] [Abstract][Full Text] [Related]
19. SC 25152: A potent mineralocorticoid antagonist with reduced affinity for the 5 alpha-dihydrotestosterone receptor of human and rat prostate.
Cutler GB; Pita JC; Rifka SM; Menard RH; Sauer MA; Loriaux DL
J Clin Endocrinol Metab; 1978 Jul; 47(1):171-5. PubMed ID: 263288
[TBL] [Abstract][Full Text] [Related]
20. Activation of the rat kidney mineralocorticoid receptor.
Eisen LP; Harmon JM
Endocrinology; 1986 Oct; 119(4):1419-26. PubMed ID: 3019632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
